StockNow
Log in
U.S. Markets

Citrini long TempusAI (TEM); Keeping Quest Diagnostics (DGX) but dropping LabCorp (LH) and putting the proceeds into TEM

StockNow breaking-news AI analysis

Investors are rotating from LabCorp to Tempus AI to capture high-growth AI oncology opportunities, while maintaining Quest Diagnostics for its stable market dominance and advanced diagnostic expansion.

3 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday